Press Releases

  • VolitionRx Limited to Present at Source Capital Group's 2nd Annual Disruptive Growth & Healthcare Conference on February 15, 2017

  • VolitionRx Limited Strengthens Team with Key Appointment to Drive Sales and Trials in Asia

  • VolitionRx Limited's Novel Cancer Diagnostic Test Achieves CE Marking as it Prepares for Launch Across Europe

  • VolitionRx Limited to Present at 9th Annual Biotech Showcase Conference

  • VolitionRx Limited to Attend Citi 2016 Global Healthcare Conference

  • VolitionRx Limited to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum 2016

  • VolitionRx Limited Announces Third Quarter 2016 Financial Results and Business Update

  • VolitionRx Limited Schedules Third Quarter 2016 Earnings Conference Call and Business Update

  • VolitionRx Limited and Hvidovre Hospital Begin Large Prospective Clinical Study

  • VolitionRx Limited Announces Acquisition of New Belgian Facility and Appointment of COO to Belgian Volition

arrow-down arrow-left arrow-right arrow chevron-down circle-link--red circle-link close play plus